STABILISATION OF BIOLOGICAL MATERIALS

Solid preparation

TABLETS COMPRISING CANDESARTAN CILEXETIL

Orally Disintegrating Tablets

METHODS AND COMPOSITONS FOR PULMONARY DELIVERY OF INSULIN

Devices, formulations, and methods for delivery of multiple beneficial agents

Diclofenac Formulations and Methods of Use

PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN

Pharmaceutical composition of amlodipine maleate having enhanced stability

Taste titration therapies

Oseltamivir phosphate granule and preparation method thereof

Cefuroxime axetil granule and process for the preparation thereof

Nanocomposite particles

Micronized opioid compositions having a specific particle size distribution

ORALLY DISINTEGRATING TABLET COMPOSITIONS OF TEMAZEPAM

CARBAMAZEPINE EXTENDED RELEASE DOSAGE FORM

Stable laquinimod preparations

Fast release solid formulation, preparation and use thereof

Solid Vaccine Formulation

PREPARATION OF POWDERS CONTAINING COLLOIDAL PARTICLES

NOVEL USES OF CHLORAMPHENICOL AND ANALOGOUS THEREOF

Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity

Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release

Shelf-Stable Famotidine Granulates for Oral Suspensions

Granular preparation containing biguanide compound

Rapidly disintegrating solid oral dosage form

Extracts of L., the compositions comprising said extracts, the preparing process and application thereof

Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin

SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS

ORAL DOSAGE FORM OF CEFTRIAXONE AND METHODS OF USE

Orally Disintegrating Powder Comprising Cilostazol and Mannitol

Pulmonary pharmaceutical formulations

CONTROLLED RELEASE SOLID PREPARATION

Composition 064

Orally disintegrating tablets

Aminodihydrothiazine derivatives

PHARMACEUTICAL FORMULATIONS

Dosage Forms Containing A PPI, NSAID And A Buffer

Sustained-release formulation

ORALLY ADMINSTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Melt granulation of a composition containing a calcium-containing compound

ORAL RAPID RELEASE PHARMACEUTICAL FORMULATION FOR PYRIDYLMETHYLSULFINYL-BENZIMIDAZOLES

Saquinavir Mesylate Oral Dosage Form

Edible powder meterial having excellent shelf stability

Method for stabilizing phenylephrine

Novel nifedipine compositions

DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION

Fenofibrate compositions

Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar

Pharmaceutical compositions of rifaximin

Solid preparation

PARTICLE AND PREPARATION CONTAINING THE PARTICLE

ENHANCED FORMULATIONS OF LAMOTRIGINE

Pharmaceutical excipient complex

Biphenyl compounds useful as muscarinic receptor antagonists

SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST

Pharmaceutical composition for reducing the area of myocardial infarction and its use

Pharmaceutical compositions for gastrointestinal drug delivery

Method for producing a powder containing xylitol crystal particles with another polyol

Nanoparticulate formulations and methods for the making and use therof

COMPOSITION COMPRISING COENZYME Q10

Fast wet-massing method for the preparation of calcium-containing compositions

Storage-Stable Oral Dosage Form of Amoxicillin and Clavulanic Acid

Dosage forms for movement disorder treatment

Respirable Powders

Film shreds and delivery system incorporating same

MULTI-FUNCTIONAL PARTICULATE DELIVERY SYSTEM FOR PHARMACOLOGICALLY ACTIVE INGREDIENTS

Powder of amino acids and method for producing the same

Pharmaceutical Composition

Oral Pharmaceutical Suspension Compositions Of Fexofenadine

Suspension formulations of insulinotropic peptides and uses thereof

High pressure spray-dry of bioactive materials

Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same

PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS

Particles for inhalation having sustained release properties

Pharmaceutical Compositions Comprising Danazol

Orodispersible tablets of bitter active principles

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

Polysaccharide microparticles containing biological agents: their preparation and applications

Coacervation Process

Oral preparation useful in measurement capacity to metabolize pyridine

Controlled release system and manufacturing method thereof

Rapidly disintegrating solid oral dosage form

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Dry granulation binders, products, and use thereof

Carotenoid-containing aqueous suspensions and powders, methods of producing the same and uses thereof

Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia

Preparation of powder agglomerates

DISINTEGRATION PROMOTERS IN SOLID DOSE WET GRANULATION FORMULATIONS

SOLID DOSE DELIVERY VEHICLE AND METHODS OF MAKING SAME

Taste masked dosage form containing roflumilast

Morphine Sulfate Formulations

Process for the precipitation and isolation of 6,6-Dimethyl-3-Aza Bicyclo [3.1.0] Hexane-Amide compounds by controlled precipitation and pharmaceutical formulations containing same

Diaminooxidase-Containing Pharmaceutical Compositions

PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED INDOLE ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)

Sterol ester powder

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Enhanced medicinal delivery system processes and products thereby especially useful for children

Microparticles containing a H+,K+-ATP-ase inhibitor

Particulate comprising a calcium-containing compound and a sugar alcohol

Methods for Obtaining a Fast Dissolving Imidapril Powder

Xylitol Granules Capable of Directly Being Compressible Into Tablets and Preparation Process Thereof

Powder formation by atmospheric spray-freeze drying

Amorphous Taclolimus Solid Dispersion Having an Enhanced Solubility and Pharmaceutical Composition Comprising Same

Pharmaceutical Compositions Containing Biophosphonate for Improving Oral Absorption

COMPRESSIBLE SOLID PARTICLES, PROCEDURES FOR THE OBTENTION THEREOF AND PROCEDURES FOR THE USE OF SAID PARTICLES IN BODY-CLEANSING TABLETS

Novel pharmaceutical dosage forms comprising valganciclovir hydrochloride

Glp-1 analogue formulations

Process for preparing a medicament

Granule formation

Preservation of bioactive materials by spray drying

Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations

Polymer-based sustained release device

Polymer-based sustained release device

Controlled-release formulations

Preparation of powder agglomerates

IBUPROFEN COMPOSITION

Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium

Biphenyl compounds useful as muscarinic receptor antagonists

Granules Comprising Paracetamol, a Nsaid and a Sugar Alchohol Made by Melt Extrusion

Biphenyl compounds useful as muscarinic receptor antagonists

Preparation and administration form comprising an acid-labile active compound

Process for preparing fenofibrate compositions

Fenofibrate compositions

Novel pharmaceutical formulations of modafinil

Fast release dosage forms for antibiotics

Dry compositions

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Spray freeze-dried compositions

Solid dosage form comprising solid dispersion

Human-powered dry powder inhaler and dry powder inhaler compositions

Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque

Bioimplant formulation comprising lecithin and stearin

Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition

Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders

Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof

AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS

Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives

PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE OF AN INSULIN SENSITISER AND ANOTHER ANTIDIABETIC AGENT

Modified Release Tablet Formulations for Proton Pump Inhibitors

Fibrin adhesive granulate and method for its preparation

Fine Particle-Containing Composition and Manufacturing Method Therefor

Biphenyl compounds useful as muscarinic receptor antagonists

Biphenyl compounds useful as muscarinic receptor antagonists

Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

Controlled agglomeration

Tablet quickly disintegrating in oral cavity

Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

Biphenyl compounds useful as muscarinic receptor antagonists

Pharmaceutical formulations

DPP IV inhibitors

Preservation of bioactive materials by spray drying

Osmotic drug delivery system

Granules Comprising a Nsaid and a Sugar Alcohol Made by Melt Extrusion

Pharmaceutical formulations of oxcarbazepine and methods for its preparation

Novel Compositions of Fat-Soluble Substances

Solid dispersion preparation

Oral dosage forms including an antiplatelet agent and an acid inhibitor

Ziprasidone Dosage Form

Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof

Methods and compositions for treatment of diastolic heart failure

Novel Co-Precipitate of Amorphous Rosiglitazone

Fine Dispersion of Sparingly Soluble Drug and Process for Producing the Same

Process for preparing oral calcium compositions

Solid dosage form of wetted heparin

Gi track delivery systems

PHARMACEUTICAL FORMULATIONS OF AN ANHYDROUS CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL

PHARMACEUTICAL FORMULATIONS OF A MONOHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL

Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same

Micronized Eplerenone Compositions

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

PHARMACEUTICAL COMPOSITIONS IN PARTICULATE FORM

Stabilized atorvastatin

Process for producing fenofibrate tablets

Particles

Pharmaceutical composition and process

Stable pharmaceutical formulations of montelukast sodium

Moisture resistant container systems for rapidly bioavailable dosage forms

Blister packaging for acute pain regimens

Process for producing fenofibrate tablets

Stable pharmaceutical formulations of montelukast sodium

Pharmaceutical formulations

Spray dried pharmaceutical compositions

Pharmaceutical compositions and methods for treating oxalate-dependent conditions

Amoxicilline instant granulate

Biguanide formulations

Prolonged release bioadhesive therapeutic systems

Multiparticulate formulations for oral delivery

Gastric release pulse system for drug delivery

Dry formulations of aripiprazole

Wet formulations of aripiprazole

Spray-dried collectin compositions and process for preparing the same

Compressed solid dosage forms with drugs of low solubility and process for making the same

Dosage forms for movement disorder treatment

PHARMACEUTICAL COMPOSITION

Pharmaceutical formulations

Medicament-containing particle and a solid preparation containing the particle

Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers

Pharmaceutical composition

Intranasal compositions

Orally administrable extended release pellet and tablet formulations of a highly water soluble compound

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Pharmaceutical formulations

PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME

Process for manufacturing chewable dosage forms for drug delivery and products thereof

PROCESS FOR THE INCORPORATION OF A FLAVOR OR FRAGRANCE INGREDIENT OR COMPOSITION INTO A CARBOHYDRATE MATRIX

Method for preparing modified release pharmaceutical compositions

Threo-DOPS controlled release formulation

Storage stable thyroxine active drug formulations and methods for their production

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS

Composition having liver function protecting effect

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

STABLE PHARMACEUTICAL COMPOSITIONS

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

Pharmaceutical compositions comprising lercanidipine

PROCESS FOR PREPARING FORMULATIONS OF LYPOPHILIC ACTIVE SUBSTANCES BY SPRAY FREEZING DRYING

Stabilisation of viral microparticles

Process for production of Bivalirudin

Dry powder composition comprising a benzodiazepine for pulmonary inhalation

Uracil reductase inactivators

Pharmaceutical Preparation containing Meloxicam

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

Composition improved in the solubility or oral absorbability

MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Dried milled granulate and methods

Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments

Particulate vitamin composition

Mouth-moistening compositions, delivery systems containing same and methods of making same

Microencapsulation and sustained release of biologically active polypeptides

Microparticles

Solid, modified-release pharmaceutical dosage forms which can be administered orally

Tablet comprising a fibrate

Tannate compositions, methods of making and methods of use

Dispersible macromolecule compositions and methods for their preparation and use

Formulations of fenofibrate containing PEG/Poloxamer

Formulations of fenofibrate containing menthol

Diclofenac formulations and methods of use

Complexation of metal ions with polypeptides

Medicated chewing gum delivery system for nicotine

Novel pharmaceutical granulate

Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

Particles for inhalation having sustained release properties

Compositions comprising fenofibrate and atorvastatin

Dosage forms for movement disorder treatment

Novel method of granulating calcium carbonate and products provided therefrom

WATER SOLUBLE ANALGESIC FORMULATIONS AND METHODS FOR PRODUCTION

Pharmaceutical composition

Methods for preparing pharmaceutical compositions

Modified release compositions comprising tacrolimus

Tanaproget compositions containing ethinyl estradiol

Pharmaceutical formulations

Pharmaceutical formulations

Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof

Extended release formulations

Oral dosage forms comprising progesterone and methods of making and using the same

Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Suspension formulation of interferon

Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent

Coated tablets

Dry powder composition comprising co-jet milled particles for pulmonary inhalation

Implantable device for continuous delivery of interferon

Taste masked sumatriptan tablets and processes for their preparation

Wet milling process

Process for producing nanoparticles by spray drying

5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl) thiazolidine-2,4-dione and pharmaceutical compositions comprising the same

Formulations of ladostigil tartrate

5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same

Stable pharmaceutical formulations of zonisamide and methods for their manufacture

Process for preparing formulations of lipid-regulating drugs

Bambuterol and integrin inhibitor combination and treatment method

Quetiapine granules

Melt-formulated, multi-particulate oral dosage form

Medicaments for the Treatment or Prevention of Fibrotic Diseases

Injectable non-aqueous suspension

Injectable non-aqueous suspension

Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria

Stable aerosol formulations of peptides and protein with non-cfc propellants

Solid dosage form comprising proton pump inhibitor and suspension made thereof

Dried product and a process for manufacturing the product

Protective barriers for micronutrients, phytochemicals, and nutraceuticals

Preparation and administration form comprising an acid-labile active compound

Use of branched malto-dextrins as granulation binders

Polymer-based sustained release device

Compositions comprising fenofibrate and simvastatin

Threo-dops controlled release formulation

Sustained release heterodisperse hydrogel systems for insoluble drugs

Fast dissolving and taste masked oral dosage form comprising sildenafil

Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets

Formulations for tyrosine kinase inhibitors

Particle formulation and its preparation

Solid dosage form comprising a fibrate and a statin

Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof

Pharmaceutical compositions for the treatment of hyper-proliferative disorders